EMCREG-International Multidisciplinary Consensus Panel on Management of Hyperkalemia in Chronic Kidney Disease and Heart Failure
Cardiorenal Medicine · 2025
DOI: 10.1159/000543385 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cardiorenal Medicine, 2025. Verfasst von Natalie Kreitzer und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, University of Cincinnati, Cincinnati, Ohio, USA. Hauptthemen laut MEDLINE: Hyperkalemia, Heart Failure, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background: Hyperkalemia, generally defined as serum potassium levels greater than 5.0 mEq/L, poses significant clinical risks, including cardiac toxicity and muscle weakness. Its prevalence and severity increase in patients with chronic kidney disease (CKD), diabetes mellitus, and heart failure (HF), particularly when compounded by medications like angiotensin converting inhibitors, angiotensin receptor blockers, and potassium sparing diuretics. Hyperkalemia arises from disruptions in potassium regulation involving intake, excretion, and intracellular-extracellular distribution. In CKD and acute kidney injury, these regulatory mechanisms are impaired, leading to heightened risk. The management of chronic hyperkalemia presents a challenge due to the necessity of balancing effective cardiovascular and renal therapies against the risk of elevated potassium levels. Summary: The emergency department management of acute hyperkalemia focuses on preventing cardiac complications through strategies that stabilize cellular membranes and shift potassium intracellularly. Chronic management often involves dietary interventions and pharmacological treatments. Pharmacological management of acute hyperkalemia includes diuretics, which enhance kaliuresis, and potassium binders such as patiromer and sodium zirconium cyclosilicate, which facilitate fecal excretion of potassium. While diuretics are commonly used, they carry risks of volume contraction and renal function deterioration. The newer potassium binders have shown efficacy in lowering chronically elevated potassium levels in CKD and HF patients, offering an alternative to diuretics and other older agents such as sodium polystyrene sulfonate, which has significant adverse effects and limited evidence for chronic use. Key Messages: We convened a consensus panel to describe the optimal management across multiple clinical settings when caring for patients with hyperkalemia. This consensus emphasizes a multidisciplinary approach to managing hyperkalemia, particularly in patients with cardiovascular kidney metabolic syndrome, to avoid fragmentation of care and ensure comprehensive treatment strategies. The primary goal of this manuscript is to describe strategies to maintain cardiovascular benefits of essential medications while effectively managing potassium levels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emergency Medicine, University of Cincinnati, Cincinnati, Ohio, USA.
- Cleveland Clinic Office of Nursing Research and Innovation and Linda H. Kaufman Center for Heart Failure, Cleveland, Ohio, USA.
- Department of Medicine, UCI School of Medicine, University of California, Irvine, California, USA.
- Pharmacy Practice and Science Department, University of Kentucky, Lexington, Kentucky, USA.
- Department of Internal Medicine, Division of Cardiovascular Health and Diseases, UC Heart, Lung, and Vascular Institute and University of Cincinnati, University of Cincinnati, Cincinnati, Ohio, USA.
- Department of Cardiology, University of California, Los Angeles, California, USA.
Zitieren
APA
Kreitzer, N., Albert, N. M., Amin, A. N., Beavers, C. J., Becker, R. C., Fonarow, G., Gibler, W. B., Kwon, K. W., Mentz, R. J., Palmer, B. F., Pollack, C. V., & Piña, I. L. (2025). EMCREG-International Multidisciplinary Consensus Panel on Management of Hyperkalemia in Chronic Kidney Disease and Heart Failure. Cardiorenal Medicine. https://doi.org/10.1159/000543385
Vancouver
Kreitzer N, Albert NM, Amin AN, Beavers CJ, Becker RC, Fonarow G, et al. EMCREG-International Multidisciplinary Consensus Panel on Management of Hyperkalemia in Chronic Kidney Disease and Heart Failure. Cardiorenal Medicine. 2025. doi:10.1159/000543385
BibTeX
@article{Kreitzer2025,
author = {Kreitzer, Natalie and Albert, Nancy M and Amin, Alpesh N and Beavers, Craig J and Becker, Richard C and Fonarow, Gregg and Gibler, W Brian and Kwon, Katherine W and Mentz, Robert J and Palmer, Biff F and Pollack, Charles V and Piña, Ileana L},
title = {EMCREG-International Multidisciplinary Consensus Panel on Management of Hyperkalemia in Chronic Kidney Disease and Heart Failure},
journal = {Cardiorenal Medicine},
year = {2025},
doi = {10.1159/000543385}
}
EUVIMED